Close Menu

NEW YORK (GenomeWeb) – A partnership between three medical and academic institutions in Heidelberg has made molecular tumor profiling available to cancer patients across Germany, impacting the treatment of many.

The initiative involves Heidelberg University Hospital's Center for Molecular Pathology, the National Center for Tumor Diseases' (NCT) Precision Oncology Program, and the German Cancer Research Institute' (DKFZ) Center for Personalized Oncology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.